During recent meetings I have attended on single use systems it is apparent that whilst there is the acceptance that single use systems are now mainstream, there are still “growing pains” within the industry. These seem to arise from expected areas such as cost of goods and supply chain timelines, but also from the transition from their use for the production of materials for clinical evaluation to long term in-market supply products. Underlying much of these discussions is t...
